High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies

摘要

Systems and methods are presented that allow for selection of tumor neoepitopes that are filtered for various criteria. In particularly contemplated aspects, filtering includes a step in which the mutation leading to the neoepitope is ascertained as being located in a cancer driver gene.